Scarica l'app Stockscreener
77.49
0.05%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$77.45
Aprire:
$77.45
Volume 24 ore:
7.08M
Relative Volume:
0.95
Capitalizzazione di mercato:
$98.28B
Reddito:
$386.46B
Utile/perdita netta:
$4.49B
Rapporto P/E:
21.62
EPS:
3.5841
Flusso di cassa netto:
$4.78B
1 W Prestazione:
+2.27%
1M Prestazione:
+5.69%
6M Prestazione:
+14.78%
1 anno Prestazione:
+23.16%
Intervallo 1D:
$77.08
$79.20
Intervallo di 1 settimana:
$73.83
$79.20
Portata 52W:
$43.56
$79.20
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
77.49 | 98.23B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
UNH
Unitedhealth Group Inc
|
360.20 | 320.35B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CI
Cigna Group
|
311.00 | 79.27B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
350.50 | 76.61B | 189.25B | 5.35B | 5.34B | 23.49 |
|
HUM
Humana Inc
|
283.72 | 30.86B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Will Caremark’s New Wegovy Copay Program Redefine CVS Health’s (CVS) Approach to Cost and Access? - Yahoo Finance
Polaris Capital Management LLC Cuts Stake in CVS Health Corporation $CVS - MarketBeat
Pure Financial Advisors LLC Purchases 3,516 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. Hits New 52-Week High at $77.54 - Markets Mojo
How CVS Health’s (CVS) Cost-Saving Overhaul in Medicare and Pharmacy Benefits Has Changed Its Investment Story - simplywall.st
Key resistance and support levels for CVS Health CorporationSell Signal & Precise Swing Trade Entry Alerts - newser.com
Health insurers to withdraw Medicare Advantage plans in Vermont and New Hampshire - Insurance Business America
Greenwood Capital Associates LLC Invests $1.31 Million in CVS Health Corporation $CVS - MarketBeat
Can CVS Health Corporation (CVS) stock attract analyst upgradesGap Down & Comprehensive Market Scan Insights - newser.com
4,250 Shares in CVS Health Corporation $CVS Purchased by Red Mountain Financial LLC - MarketBeat
Will CVS Health Corporation stock deliver consistent dividends2025 Earnings Surprises & Verified Technical Trade Signals - newser.com
What is the fair value estimate for CVS Health Corporation (CVS) stock in 2025New Guidance & Expert Approved Momentum Trade Ideas - newser.com
Forecasting CVS Health Corporation price range with options dataQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
Aetna Announces 2026 Medicare Advantage Plans - Managed Healthcare Executive
UnitedHealth to exit Medicare Advantage plans in 109 US counties - Reuters
Major health insurers scaling back Medicare Advantage offerings in 2026 - Fox Business
CVS Health Corporation $CVS Shares Acquired by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat
CVS Health Corporation $CVS Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
USA Financial Formulas Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Greenleaf Trust - MarketBeat
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
CVS Health (NYSE:CVS) Reaches New 1-Year HighTime to Buy? - MarketBeat
CVS dangles $200 copays for Wegovy in bid to expand coverage - The Spokesman-Review
US health insurers reduce Medicare Advantage operations in 2026 - Reuters
CVS (CVS) Pushes for Lower Copay on Novo Nordisk's Wegovy - GuruFocus
CVS Dangles $200 Copays for Wegovy in Bid to Expand Coverage - Bloomberg.com
UnitedHealth, CVS Health drop Medicare offerings (UNH:NYSE) - Seeking Alpha
CVS PBM Caremark exploring $200 copay for Novo Nordisk's Wegovyreport - Seeking Alpha
CVS Health stock hits 52-week high at 77.43 USD By Investing.com - Investing.com Australia
CVS Health stock hits 52-week high at 77.43 USD - Investing.com
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away - Benzinga
US health insurers reduce Medicare Advantage operations in 2026 By Reuters - Investing.com
CVS Health, Humana to reduce Medicare Advantage operations in 2026 - Yahoo Finance
What RSI levels show for CVS Health Corporation (Common Stock) (CVS0) stock2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
CVS Health stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com
Cvs Health CorpAetna announces its 2026 Medicare Advantage plans - MarketScreener
Earnings visualization tools for CVS Health CorporationEarnings Beat & Safe Swing Trade Setups - newser.com
Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care - CVS Health
$0 Copays and 57M Beneficiary Access: Aetna's 2026 Medicare Advantage Plan Brings Major Expansion - Stock Titan
Lbp Am Sa Raises Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Columbia Asset Management - MarketBeat
Capital Investment Advisors LLC Sells 10,382 Shares of CVS Health Corporation $CVS - MarketBeat
CVS, CareFirst BlueCross BlueShield hit with class action lawsuit for denying coverage of Zepbound sleep apnea treatment - Class Action Lawsuits
Bank of America Securities Maintains a Buy on CVS Health Corporation (CVS) - Insider Monkey
CVS Health’s (CVS) Payout Strength Compared to Other October Dividend Stocks - Insider Monkey
Top Investment Magazine BetterInvesting Highlights Vertiv Holdings and CVS Health for December Study Focus - Stock Titan
Healthcare Giant CVS Health to Report Q3 2025 Results: What Investors Need to Know About October 29 Call - Stock Titan
First United Bank & Trust Has $682,000 Stock Position in CVS Health Corporation $CVS - MarketBeat
Centennial Wealth Advisory LLC Purchases New Position in CVS Health Corporation $CVS - MarketBeat
V Square Quantitative Management LLC Sells 6,605 Shares of CVS Health Corporation $CVS - MarketBeat
How CVS Health Corporation (CVS) stock compares with tech leadersPortfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):